With U.S. diagnoses of Parkinson's expected to reach 1.2 million by 2030, research is in full swing, and treatments ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

The common myths about Parkinson’s disease and treatments - People have lots of misconceptions about Parkinson’s disease and how it develops, here are the ...

One of the defining features of Parkinson’s is the presence of abnormal protein clumps in the brain known as Lewy bodies.

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

Researchers led by a team from the University of Bath in the UK have achieved just that in a basic worm model of Parkinson's.

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...